MSB 3.76% $1.03 mesoblast limited

Wes, A clue here for JCR penetration, can be found in JCR's own...

  1. 4,133 Posts.
    lightbulb Created with Sketch. 5378
    Wes,

    A clue here for JCR penetration, can be found in JCR's own comments from a few years back.

    July 31 - 2020
    "JCR Pharmaceuticals Co., Ltd. to Expand the Manufacturing Area to Increase Production Capacity for TEMCELL HS Injection"
    Medical institutions have highly rated TEMCELL® HS Inj. since its launch in 2016 and JCR
    has received orders far in excess of its initial forecasts"

    "This expansion will raise the production capacity for TEMCELL® HS Inj. by about 30% over current levels, ensure an appropriate inventory and enable sufficient supply to meet the market's robust demand"


    MSB recieved royalty revenue Jul19 - Jun20 of US 6.6 million. ( Pre JCR 30% increase in manufacturing )

    MSB recieved royalty revenue Jul22 - Jun23 of US 7.48 million. ( Post Covid & JCR 30% increase in manufacturing )

    Royalty Increase of 13%, however I suspect these results would have been heavily impacted by Covid in a multitude of ways.

    If JCR manage 40 - 50% market penetration with lower survival than Ryoncil, I guess we will get higher penetration.








 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.07 $1.07 $1.01 $13.19M 12.81M

Buyers (Bids)

No. Vol. Price($)
3 61090 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 239558 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.